A transgenic mouse model of heart failure using inducible Gαq
A transgenic mouse model of heart failure using inducible Gαq
复制标题
DOI:
10.1074/jbc.m506810200
复制
发表时间:
2005-12-02
影响因子:
4.8
通讯作者:
Lin, RZ
中科院分区:
文献类型:
--
作者:
Fan, GF;Jiang, YP;Lin, RZ
Receptors coupled to G alpha(q) play a key role in the development of heart failure. Studies using genetically modified mice suggest that G alpha(q) mediates a hypertrophic response in cardiac myocytes. G alpha(q) signaling in these models is modified during early growth and development, whereas most heart failure in humans occurs after cardiac damage sustained during adulthood. To determine the phenotype of animals that express increased G alpha(q) signaling only as adults, we generated transgenic mice that express a silent G alpha(q) protein (G alpha(q) Q209L- hbER) in cardiac myocytes that can be activated by tamoxifen. Following drug treatment to activate G alpha(q)Q209L- hbER, these mice rapidly develop a dilated cardiomyopathy and heart failure. This phenotype does not appear to involve myocyte hypertrophy but is associated with dephosphorylation of phospholamban ( PLB), decreased sarcoplasmic reticulum Ca2+- ATPase activity, and a decrease in L-type Ca2+ current density. Changes in Ca2+ handling and decreased cardiac contractility are apparent 1 week after (G alpha(q) Q209L-hbER) activation. In contrast, transgenic mice that express an inducible G alpha(q) mutant that cannot activate phospholipase C beta (PLC beta) do not develop heart failure or changes in PLB phosphorylation, but do show decreased L-type Ca2+ current density. These results demonstrate that activation of G alpha(q) in cardiac myocytes of adult mice causes a dilated cardiomyopathy that requires the activation of PLC . However, increased PLC beta signaling is not required for all of the G alpha(q)-induced cardiac abnormalities.